methylphosphonic acid has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deisseroth, A; Lopez-Berestein, G; Tari, AM; Tucker, SD | 1 |
| Beardsley, T | 1 |
2 other study(ies) available for methylphosphonic acid and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Liposomal delivery of methylphosphonate antisense oligodeoxynucleotides in chronic myelogenous leukemia.
Topics: Base Sequence; Cell Division; Drug Carriers; Fusion Proteins, bcr-abl; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liposomes; Molecular Sequence Data; Oligonucleotides, Antisense; Organophosphorus Compounds; Tumor Cells, Cultured | 1994 |
Making antisense. Drugs that turn off genes are entering human tests.
Topics: DNA, Antisense; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Organophosphorus Compounds | 1992 |